Seoul National University Bundang Hospital Reports Findings in Lung Cancer (Epidemiologic Study of Epidural Analgesia for Lung Cancer Surgery from 2011 to 2018 in South Korea: A National Health Insurance Database Cohort Study): Oncology – Lung Cancer

2022 JUL 27 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Business Daily -- New research on Oncology - Lung Cancer is the subject of a report. According to news reporting out of Seongnam, South Korea, by NewsRx editors, research stated, “Epidural analgesia is commonly used for pain control during lung cancer surgery. However, the clinical trends in epidural analgesia, associated factors, and their association with clinical outcomes remain controversial.”

Our news journalists obtained a quote from the research from Seoul National University Bundang Hospital, “Therefore, we aimed to investigate the trends, associated factors, and their association with the clinical outcomes of epidural analgesia for lung cancer surgery. The National Health Insurance Database was used as the data source in a nationwide cohort study. All adult patients who underwent lung cancer surgery between 2011 and 2018 were included. A total of 60,031 adult patients who underwent surgery for lung cancer were included. Of these, a total of 24,786 patients (41.3%) received epidural analgesia with a mean value of 1.5 days (standard deviation: 2.0 days). Male sex, increased Charlson comorbidity index, concurrent musculoskeletal disease, and a wider surgical extent were associated with higher odds of epidural analgesia for lung cancer surgery. Compared to open thoracotomy, video-assisted thoracoscopic surgery (VATS) was associated with lower odds of epidural analgesia for lung cancer surgery. Moreover, epidural analgesia was not associated with 30-day mortality, fatal respiratory events, or 1-year mortality after lung cancer surgery. From 2011 to 2018, 41.3% of patients with lung cancer in South Korea received epidural analgesia for lung cancer surgery. Some factors (male sex, increased Charlson comorbidity index, concurrent musculoskeletal disease, wider surgical extent, and VATS) were associated with the use of epidural analgesia in lung cancer surgery.”

According to the news editors, the research concluded: “However, epidural analgesia was not associated with clinical outcomes after lung cancer surgery.”

For more information on this research see: Epidemiologic Study of Epidural Analgesia for Lung Cancer Surgery from 2011 to 2018 in South Korea: A National Health Insurance Database Cohort Study. Korean Journal of Anesthesiology, 2022. Korean Journal of Anesthesiology can be contacted at: Korean Soc Anesthesiologists, 101-3503, Lotte Castle President, 109 Mapo-Daero, Mapo-Gu, Seoul, South Korea.

Our news journalists report that additional information may be obtained by contacting In-Ae Song, Dept. of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.4097/kja.22089. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Publisher contact information for the Korean Journal of Anesthesiology is: Korean Soc Anesthesiologists, 101-3503, Lotte Castle President, 109 Mapo-Daero, Mapo-Gu, Seoul, South Korea.

(Our reports deliver fact-based news of research and discoveries from around the world.)